Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

575
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
575
Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Cancer Prevention02:59

Cancer Prevention

7.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-population metabolome-wide Mendelian randomization study of prostate cancer risk.

Research square·2026
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026
Same author

MyGeneRisk Colon: A Web-Based Tool for Personalized Colorectal Cancer Risk Prediction Based on Genetics and Lifestyle.

medRxiv : the preprint server for health sciences·2026
Same author

Sensitive Period Analysis of Adulthood BMI and Cancer Risk: An Individual Participant Data Meta-Analysis of Over 720,000 Participants in the ABACus 2 Consortium.

International journal of cancer·2026
Same author

TGF-β Pathway-Based Polygenic Risk Score Modifies the Association between Red Meat Intake and Colorectal Cancer Risk: Application of a Novel Pathway-Based PRS Method.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Identifying Plasma Proteins Associated with Risk of Solid Cancers: A 25-Year Prospective Analysis of 4,712 Circulating Proteins in the ARIC Study.

medRxiv : the preprint server for health sciences·2026
Same journal

Harnessing Multiteam Systems in the Development of a Multifaceted Data Repository for Emergency Public Health Response.

Journal of public health management and practice : JPHMP·2026
Same journal

Rhode Island's Centralized Rabies Control Program: Reducing Unnecessary Postexposure Prophylaxis and Associated Health Care Savings.

Journal of public health management and practice : JPHMP·2026
Same journal

Working With Risk: Improving Collection of Industry and Occupation Data During Public Health Surveillance Case Follow-Up in Wisconsin.

Journal of public health management and practice : JPHMP·2026
Same journal

Implementing Levels of Maternal Care: Common Challenges and Promising Strategies.

Journal of public health management and practice : JPHMP·2026
Same journal

Public Health Disease Intervention Job Posting Analysis: Current Trends to Build a Future Workforce.

Journal of public health management and practice : JPHMP·2026
Same journal

Strengthening Local Health Department Capacity for Healthcare Infection Prevention and Control Through NACCHO's Project Firstline.

Journal of public health management and practice : JPHMP·2026
See all related articles

Related Experiment Video

Updated: Dec 18, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

564

Progress in Cancer Control in Maryland: 1985-2015.

Victoria Brun1, Elizabeth A Platz, Thuy Nguyen

  • 1Frederick National Laboratory for Cancer Research, Frederick, Maryland (Ms Brun); Departments of Epidemiology (Dr Platz) and Environmental Health and Engineering (Dr Kanarek), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland (Dr Platz and Dr Kanarek); Center for Cancer Prevention and Control, Prevention and Health Promotion Administration, Maryland Department of Health, Baltimore, Maryland (Ms Nguyen and Gugel); Discern Health, formerly of the Prevention and Health Promotion Administration, Maryland Department of Health, Baltimore, Maryland (Ms Valek); and University of Maryland Medical Center, Baltimore, Maryland (Ms Warmkessel).

Journal of Public Health Management and Practice : JPHMP
|June 11, 2020
PubMed
Summary
This summary is machine-generated.

Maryland has significantly reduced cancer mortality over 30 years, outperforming other states. Despite this progress, high cancer incidence suggests a need for increased primary prevention efforts to further combat cancer burden.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

420

Related Experiment Videos

Last Updated: Dec 18, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

564
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

420

Area of Science:

  • Public Health
  • Cancer Control
  • Epidemiology

Background:

  • Maryland historically faced a high cancer burden, necessitating robust cancer control strategies.
  • The state's cancer control efforts have evolved under successive Maryland Comprehensive Cancer Control Plans.

Purpose of the Study:

  • To evaluate the current status of cancer in Maryland.
  • To assess the impact of past and present Maryland Comprehensive Cancer Control Plans.

Main Methods:

  • Analysis of cancer mortality, incidence, and behavioral data from 1985-2015.
  • Utilized data from US Cancer Control PLANET, CDC WONDER, and BRFSS.
  • Estimated annual cancer deaths avoided using triangulation methods.

Main Results:

  • Maryland's age-adjusted cancer mortality rate improved from highest nationally (1983-1987) to 31st (2011-2015).
  • Cancer mortality declined 1.9% annually (1990-2015), avoiding nearly 60,000 deaths.
  • Cancer incidence rates in Maryland (2011-2015) were higher than the US average, despite similar or better cancer-related behaviors.

Conclusions:

  • Maryland's 30-year cancer mortality reduction exceeds national trends.
  • Sustained high cancer incidence alongside declining mortality highlights the critical need for enhanced primary prevention strategies.